Engineering macrophages to eat cancer: from “marker of self” CD47 and phagocytosis to differentiation-Reference-Cited by-同舟云学术

Engineering macrophages to eat cancer: from “marker of self” CD47 and phagocytosis to differentiation

Published:2017-05-18 Issue:1 Volume:102 Page:31-40
ISSN:0741-5400
Container-title:Journal of Leukocyte Biology
language:en
Short-container-title:Journal of Leukocyte Biology

Author:

Alvey Cory¹,Discher Dennis E.¹

Affiliation:

1. Systems Pharmacology and Translational Therapeutics Graduate Group, Physical Sciences Oncology Center at Penn, Molecular and Cell Biophysics Laboratory, University of Pennsylvania, Philadelphia, Pennsylvania, USA

Funder

National Institutes of Health

National Cancer Institute

National Heart, Lung, and Blood Institute

National Institute of Diabetes and Digestive and Kidney Diseases

National Science Foundation

Publisher

Wiley

Subject

Cell Biology,Immunology,Immunology and Allergy

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1189/jlb.4RI1216-516R

Reference110 articles.

1. Tissue-Resident Macrophage Enhancer Landscapes Are Shaped by the Local Microenvironment

2. Environment Drives Selection and Function of Enhancers Controlling Tissue-Specific Macrophage Identities

3. Lymphokine‐activated human blood monocytes destroy tumor cells but not normal cells under cocultivation conditions;Fidler I. J.;J. Clin. Oncol.,1984

4. Macrophages: Obligate Partners for Tumor Cell Migration, Invasion, and Metastasis

5. Increase in tumor-associated macrophages after antiangiogenic therapy is associated with poor survival among patients with recurrent glioblastoma

Cited by 51 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Antibody surface mobility amplifies FcγR signaling via Arp2/3 during phagocytosis;Biophysical Journal;2024-08

2. Plasma membrane abundance dictates phagocytic capacity and functional cross-talk in myeloid cells;Science Immunology;2024-06-07

3. Gentulizumab, a novel anti-CD47 antibody with potent antitumor activity and demonstrates a favorable safety profile;Journal of Translational Medicine;2024-03-01

4. Nanoparticle-based immunoengineering strategies for enhancing cancer immunotherapy;Journal of Controlled Release;2024-01

5. Immune Cells: Critical Players in Drug Resistance;Drug Resistance in Cancer: Mechanisms and Strategies;2024